Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO) is an artificial-intelligence-powered cardiovascular diagnostics company that reached the public markets through a business combination with Mana Capital Acquisition Corp., a blank-check vehicle sponsored by Mana Capital LLC that completed its initial public offering in 2021. The company operates in the healthcare and medical diagnostics sector, applying epigenetics-based technology alongside AI to cardiovascular disease detection and risk stratification. As of its Form 8-K filing dated May 31, 2022, Cardio Diagnostics was operating as a publicly traded post-combination entity on Nasdaq. For comprehensive filing history, deal timelines, and real-time SPAC data on CDIO and hundreds of other transactions, sign up for full access at SpacDesk.